Trials
Search / Trial NCT06614023

Impact of Body Weight on Outcomes of Patients Undergoing Coronary Artery Bypass Grafting

Launched by MEDICAL UNIVERSITY OF SILESIA · Sep 23, 2024

Apply for Trial

Trial Information

Current as of March 07, 2025

Completed

Keywords

Body Mass Index Coronary Artery Bypass Grafting Obesity Mortality

ClinConnect Summary

All consecutive patients aged above eighteen who underwent isolated CABG were enrolled. Patients operated on- and off-pump were included. We reviewed elective, urgent, emergency and salvage surgeries. Patients with any additional concomitant surgical procedures were excluded.

Patients were divided into 6 groups according to body mass index (BMI): underweight (BMI \<20.0 kg/m2), normal weight (BMI 20.0-24.9 kg/m2), overweight (BMI, 25-29.9 kg/m2), obesity class I (BMI 30-34.9 kg/m2), obesity class II (BMI 35-39.9 kg/m2) and obesity class III (BMI \>40 kg/m2).

The primary endpoint was...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • patients undergoing isolated CABG
  • Exclusion Criteria:
  • • any concomitant additional surgical procedures

About Medical University Of Silesia

The Medical University of Silesia is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. Located in Poland, the university is renowned for its commitment to medical education, interdisciplinary collaboration, and the development of new therapeutic approaches. With a focus on translating scientific discoveries into practical applications, the Medical University of Silesia sponsors a range of clinical trials aimed at improving patient outcomes and enhancing the understanding of various medical conditions. Through its rigorous ethical standards and robust research infrastructure, the university plays a pivotal role in shaping the future of medicine both regionally and globally.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0